Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6394 ↗At a glance
Metaanalyse in Prenatal Diagnosis, 2023. Written by Ailsa Borbolla Foster and 2 co-authors. Institution: Department of Maternal and Fetal Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia. Major MEDLINE topics: Pre-Eclampsia, Maternal Health Services. Cited 11 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Objective
Traditional obstetric practice relies upon history‐based assessment to screen for preeclampsia and guide preventative therapies but is hampered by low sensitivity, high false‐positive rates and low treatment rates. First‐trimester screening algorithms represent the most efficacious approach for risk prediction and could target early initiation of aspirin to well‐defined high‐risk populations. A large randomised controlled trial has demonstrated the clinical benefits of this approach, but widespread practice implementation has remained elusive.
Methods
We performed a systematic review and meta‐analysis summarising studies linking first‐trimester preeclampsia screening algorithms with the initiation of preventative therapy and examined their effect on pre‐term preeclampsia rates compared with standard maternity care. Odds ratios were calculated together with 95% confidence intervals.
Results
7 studies with a total of 377,790 participants were included. Within singleton populations, early initiation of aspirin in response to a high‐risk screening algorithm result reduced the prevalence of pre‐term preeclampsia by 39% compared with routine antenatal care (odds ratio 0.61; 95% CI: 0.52–0.70). There were significant reductions in the prevalence of preeclampsia at
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Maternal and Fetal Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
- Faculty of Medicine, University of Newcastle, Newcastle, New South Wales, Australia.
- Ingham Institute for Applied Medical Research, Liverpool Hospital, Liverpool, New South Wales, Australia.
- Deprtment of Obstetrics and Gynaecology, Faculty of Medicine, Western Sydney University, Newcastle, New South Wales, Australia.
ORCID profiles: Ailsa Borbolla Foster
Cite
APA
Foster, A. B., Park, F., & Hyett, J. (2023). Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis. Prenatal Diagnosis. https://doi.org/10.1002/pd.6394
Vancouver
Foster AB, Park F, Hyett J. Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis. Prenatal Diagnosis. 2023. doi:10.1002/pd.6394
BibTeX
@article{Foster2023,
author = {Foster, Ailsa Borbolla and Park, Felicity and Hyett, Jon},
title = {Do first‐trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre‐term preeclampsia: A systematic review and meta‐analysis},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6394}
}
EUVIMED